Cardiac glycosides in the next millennium
- 28 February 1999
- journal article
- review article
- Published by Elsevier BV in Progress in Cardiovascular Diseases
- Vol. 41 (4), 247-254
- https://doi.org/10.1053/pcad.1999.0410247
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Pharmacotherapy for Systolic Dysfunction: A Review of Randomized Clinical TrialsThe American Journal of Cardiology, 1997
- Influence of Isoproterenol and Ouabain on Excitation-Contraction Coupling, Cross-Bridge Function, and Energetics in Failing Human MyocardiumCirculation, 1996
- Digoxin reduces cardiac sympathetic activity in severe congestive heart failureJournal of the American College of Cardiology, 1996
- Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failureJournal of the American College of Cardiology, 1995
- Double-Blind Placebo-Controlled Study of Ibopamine and Diagoxin in Patients With Mild to Moderate Heart Failure: Results of the Dutch of the Ibopamine Multicenter Trial (DIMT)Journal of the American College of Cardiology, 1993
- Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings.Circulation, 1989
- Comparative hemodynamic and neurohormonal effects of intravenous captopril and digoxin and their combinations in patients with severe heart failureJournal of the American College of Cardiology, 1989
- Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilatorsJournal of the American College of Cardiology, 1987
- Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: A hemodynamic-hormonal studyThe American Journal of Cardiology, 1985
- Studies on Digitalis. X. Effects of Ouabain on Forearm Vascular Resistance and Venous Tone in Normal Subjects and in Patients in Heart Failure *JCI Insight, 1964